GSK PLC-SPON ADR (GSK:NYSE)
$52.59 0.37 (0.7085%)
Analysed GSK PLC-SPON ADR (GSK:NYSE) News Sources
Can Gilead Sciences HIV Franchise Drive Long-Term Growth?
10-06-2026
yahoo.com
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
11-06-2026
marketbeat.com
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
11-06-2026
yahoo.com
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder
12-06-2026
yahoo.com
GSK Engitix Liver Fibrosis Pact Adds Early Stage Upside For Valuation
13-06-2026
yahoo.com
MarketBeat Week in Review – 06/08 - 06/12
13-06-2026
marketbeat.com
Sector Update: Healthcare Stocks Advance in Afternoon Trading
16-06-2026
yahoo.com
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention
16-06-2026
yahoo.com
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
16-06-2026
yahoo.com
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
17-06-2026
yahoo.com
What is the current price of GSK PLC-SPON ADR (GSK:NYSE)?
The current price of GSK PLC-SPON ADR (GSK:NYSE) is $52.59.
GSK PLC-SPON ADR (GSK:NYSE) absolute price change since previous trading day?
The absolute price change of GSK PLC-SPON ADR (GSK:NYSE) since the previous trading day is $0.37.
GSK PLC-SPON ADR (GSK:NYSE) percentage price change since previous trading day?
The percentage price change of GSK PLC-SPON ADR (GSK:NYSE) since the previous trading day is 0.7085%.
What is the most recent average sentiment score for GSK PLC-SPON ADR (GSK:NYSE)?
The most recent average sentiment score for GSK PLC-SPON ADR (GSK:NYSE) is 74 out of 100.
What is the most recent average sentiment for GSK PLC-SPON ADR (GSK:NYSE)?
The most recent sentiment for GSK PLC-SPON ADR (GSK:NYSE) is .
SEC-8K** Filing Available For GSK PLC-SPON ADR (GSK:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.